Green Square Capital LLC increased its position in CVS Health Corporation (NYSE:CVS) by 0.2% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 8,542 shares of the pharmacy operator’s stock after buying an additional 13 shares during the period. Green Square Capital LLC’s holdings in CVS Health Corporation were worth $818,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. State Street Corp boosted its stake in CVS Health Corporation by 2.4% in the first quarter. State Street Corp now owns 44,552,112 shares of the pharmacy operator’s stock worth $4,621,391,000 after buying an additional 1,023,799 shares in the last quarter. Nordea Investment Management AB boosted its stake in CVS Health Corporation by 61.3% in the second quarter. Nordea Investment Management AB now owns 11,644,431 shares of the pharmacy operator’s stock worth $1,114,838,000 after buying an additional 4,423,216 shares in the last quarter. Geode Capital Management LLC boosted its stake in CVS Health Corporation by 0.9% in the first quarter. Geode Capital Management LLC now owns 8,917,040 shares of the pharmacy operator’s stock worth $923,085,000 after buying an additional 77,690 shares in the last quarter. Legal & General Group Plc boosted its stake in CVS Health Corporation by 1.9% in the first quarter. Legal & General Group Plc now owns 4,961,136 shares of the pharmacy operator’s stock worth $514,632,000 after buying an additional 92,196 shares in the last quarter. Finally, UBS Asset Management Americas Inc. boosted its stake in CVS Health Corporation by 12.6% in the first quarter. UBS Asset Management Americas Inc. now owns 4,764,859 shares of the pharmacy operator’s stock worth $494,259,000 after buying an additional 531,568 shares in the last quarter. 80.96% of the stock is owned by institutional investors and hedge funds.
Shares of CVS Health Corporation (NYSE:CVS) traded down 0.02% during trading on Wednesday, reaching $86.20. The company’s stock had a trading volume of 7,949,261 shares. The firm has a market cap of $91.91 billion, a PE ratio of 19.83 and a beta of 0.83. CVS Health Corporation has a 12 month low of $85.89 and a 12 month high of $106.67. The stock’s 50 day moving average price is $92.04 and its 200-day moving average price is $97.10.
CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.30 by $0.02. CVS Health Corporation had a return on equity of 15.86% and a net margin of 2.88%. The firm earned $43.70 billion during the quarter, compared to the consensus estimate of $44.28 billion. During the same period last year, the business posted $1.19 EPS. The business’s revenue was up 17.6% compared to the same quarter last year. Equities analysts predict that CVS Health Corporation will post $5.86 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 3rd. Shareholders of record on Monday, October 24th will be issued a dividend of $0.425 per share. The ex-dividend date is Thursday, October 20th. This represents a $1.70 dividend on an annualized basis and a yield of 1.97%. CVS Health Corporation’s payout ratio is currently 39.08%.
A number of equities research analysts recently weighed in on the company. Leerink Swann reaffirmed a “buy” rating on shares of CVS Health Corporation in a report on Friday, June 10th. Zacks Investment Research raised CVS Health Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, August 3rd. FBR & Co reissued an “outperform” rating and issued a $120.00 target price on shares of CVS Health Corporation in a research note on Wednesday, August 3rd. Morgan Stanley reissued a “hold” rating and issued a $104.00 target price on shares of CVS Health Corporation in a research note on Wednesday, August 3rd. Finally, Argus reissued a “buy” rating and issued a $120.00 target price on shares of CVS Health Corporation in a research note on Thursday, August 4th. Six investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $112.44.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.